The 5-year survival rate for neuroblastoma is approximately 71%. Neuroblastoma is one of the most common solid tumors in childhood, but clinically it is a rare disease, and children are the main incidence population. According to the expert consensus on the diagnosis and treatment of neuroblastoma in children issued by the Chinese Journal of Pediatric Surgery, it can be understood that at present, after years of efforts in the international arena, the 5-year survival rate of neuroblastoma has been raised to 71%, but at present, there are still discrepancies between the diagnosis and treatment of neuroblastoma in China and the international arena. Neuroblastoma is a kind of tumor disease with strong heterogeneity, and most of the patients have insidious onset and rapid progression of the disease, therefore, once the relevant symptoms appear, it is necessary to seek professional physician’s help in time.